• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中事件发生时间终点监测的里程碑预测。

Milestone prediction for time-to-event endpoint monitoring in clinical trials.

作者信息

Ou Fang-Shu, Heller Martin, Shi Qian

机构信息

Department of Health Sciences Research, Mayo Clinic Cancer Center, Rochester, MN, USA.

Private Practitioner, Rochester, MN, USA.

出版信息

Pharm Stat. 2019 Jul;18(4):433-446. doi: 10.1002/pst.1934. Epub 2019 Feb 26.

DOI:10.1002/pst.1934
PMID:30806485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6777948/
Abstract

Predicting the times of milestone events, ie, interim and final analyses in clinical trials, helps resource planning. This manuscript presents and compares several easily implemented methods for predicting when a milestone event is achieved. We show that it is beneficial to combine the predictions from different models to craft a better predictor through prediction synthesis. Furthermore, a Bayesian approach provides a better measure of the uncertainty involved in prediction of milestone events. We compare the methods through two simulations where the model has been correctly specified and where the models are a mixture of three incorrectly specified model classes. We then apply the methods on two real clinical trial data, North Central Cancer Treatment Group (NCCTG) N0147 and N9841. In summary, the Bayesian prediction synthesis methods automatically perform well even when the data collection is far from homogeneous. An R shiny app is under development to carry out the prediction in a user-friendly fashion.

摘要

预测里程碑事件的时间,即临床试验中的中期和最终分析,有助于资源规划。本文介绍并比较了几种易于实施的预测里程碑事件实现时间的方法。我们表明,通过预测合成将不同模型的预测结果结合起来以构建更好的预测器是有益的。此外,贝叶斯方法能更好地衡量里程碑事件预测中涉及的不确定性。我们通过两个模拟对这些方法进行比较,一个模拟中模型已正确设定,另一个模拟中模型是由三个设定错误的模型类别混合而成。然后我们将这些方法应用于两个真实的临床试验数据,即北中部癌症治疗组(NCCTG)的N0147和N9841。总之,即使数据收集远非同质,贝叶斯预测合成方法也能自动表现良好。一个R闪亮应用程序正在开发中,以便以用户友好的方式进行预测。

相似文献

1
Milestone prediction for time-to-event endpoint monitoring in clinical trials.临床试验中事件发生时间终点监测的里程碑预测。
Pharm Stat. 2019 Jul;18(4):433-446. doi: 10.1002/pst.1934. Epub 2019 Feb 26.
2
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.二分类变量生物标志物与临床终点之间的贝叶斯预测模型。
Trials. 2014 Dec 20;15:500. doi: 10.1186/1745-6215-15-500.
3
Monitoring event times in early phase clinical trials: some practical issues.早期临床试验中的事件时间监测:一些实际问题。
Clin Trials. 2005;2(6):467-78. doi: 10.1191/1740774505cn121oa.
4
Predicting event times in clinical trials when randomization is masked and blocked.在随机化被掩盖和分组的情况下预测临床试验中的事件时间。
Clin Trials. 2007;4(5):481-90. doi: 10.1177/1740774507083390.
5
Adaptive parametric prediction of event times in clinical trials.临床试验中事件时间的自适应参数预测。
Clin Trials. 2018 Apr;15(2):159-168. doi: 10.1177/1740774517750633. Epub 2018 Jan 29.
6
Predicting analysis times in randomized clinical trials.随机临床试验中的分析时间预测
Stat Med. 2001 Jul 30;20(14):2055-63. doi: 10.1002/sim.843.
7
Predicting event times in clinical trials when treatment arm is masked.在治疗组被设盲的情况下预测临床试验中的事件发生时间。
J Biopharm Stat. 2006 May;16(3):343-56. doi: 10.1080/10543400600609445.
8
Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate information.利用累积事件发生时间替代信息预测事件驱动型临床试验中的分析时间。
Pharm Stat. 2016 May;15(3):198-207. doi: 10.1002/pst.1732. Epub 2015 Dec 22.
9
Prediction of event times in the REMATCH Trial.REMATCH 试验中事件时间的预测。
Clin Trials. 2013 Apr;10(2):197-206. doi: 10.1177/1740774512470314. Epub 2013 Jan 15.
10
Weibull prediction of event times in clinical trials.临床试验中事件时间的威布尔预测。
Pharm Stat. 2008 Apr-Jun;7(2):107-20. doi: 10.1002/pst.271.

本文引用的文献

1
Adaptive parametric prediction of event times in clinical trials.临床试验中事件时间的自适应参数预测。
Clin Trials. 2018 Apr;15(2):159-168. doi: 10.1177/1740774517750633. Epub 2018 Jan 29.
2
Predicting analysis times in randomized clinical trials with cancer immunotherapy.癌症免疫疗法随机临床试验中的分析时间预测分析
BMC Med Res Methodol. 2016 Feb 1;16:12. doi: 10.1186/s12874-016-0117-3.
3
Discussion on the paper "Real-Time Prediction of Clinical Trial Enrollment and Event Counts: A Review", by DF Heitjan, Z Ge, and GS Ying.
关于DF·海特扬、Z·葛和GS·英所著论文《临床试验入组和事件计数的实时预测:综述》的讨论
Contemp Clin Trials. 2016 Jan;46:7-10. doi: 10.1016/j.cct.2015.11.008. Epub 2015 Nov 10.
4
Real-time prediction of clinical trial enrollment and event counts: A review.临床试验入组和事件计数的实时预测:综述
Contemp Clin Trials. 2015 Nov;45(Pt A):26-33. doi: 10.1016/j.cct.2015.07.010. Epub 2015 Jul 16.
5
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.奥沙利铂、氟尿嘧啶和亚叶酸联合或不联合西妥昔单抗治疗可切除的 III 期结肠癌患者的生存影响:一项随机试验。
JAMA. 2012 Apr 4;307(13):1383-93. doi: 10.1001/jama.2012.385.
6
Predictive event modelling in multicenter clinical trials with waiting time to response.具有反应等待时间的多中心临床试验中的预测事件建模
Pharm Stat. 2011 Nov-Dec;10(6):517-22. doi: 10.1002/pst.525. Epub 2011 Dec 5.
7
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.一项III期非劣效性试验,比较伊立替康与奥沙利铂、氟尿嘧啶和亚叶酸钙用于先前接受过氟尿嘧啶治疗的晚期结直肠癌患者:N9841。
J Clin Oncol. 2009 Jun 10;27(17):2848-54. doi: 10.1200/JCO.2008.20.4552. Epub 2009 Apr 20.
8
Predicting accrual in clinical trials with Bayesian posterior predictive distributions.利用贝叶斯后验预测分布预测临床试验中的病例数积累。
Stat Med. 2008 Jun 15;27(13):2328-40. doi: 10.1002/sim.3128.
9
Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.多中心试验中招募的建模、预测与适应性调整
Stat Med. 2007 Nov 30;26(27):4958-75. doi: 10.1002/sim.2956.
10
Nonparametric prediction of event times in randomized clinical trials.随机临床试验中事件时间的非参数预测
Clin Trials. 2004;1(4):352-61. doi: 10.1191/1740774504cn030oa.